ArticleKorean journal of pediatrics2013

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia.

Hyun Jin Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.